Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02273973
Title Study of Neoadjuvant Letrozole + GDC-0032 Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Genentech, Inc.
Indications

Her2-receptor negative breast cancer

Therapies

Taselisib

Age Groups: adult
Covered Countries USA


No variant requirements are available.